Association of TNFA (−308G>A) and IL-10 (−819C>T) Promoter Polymorphisms With Risk of Cervical Cancer
Authors:
- Meenu JainMJMeenu Jain
- Rekha SachanRSRekha Sachan
- Balraj MittalBMBalraj Mittal
- 1 October 2009
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 19 (7) , 1190-1194
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- TNFα blockade in human diseases: Mechanisms and future directionsClinical Immunology, 2008
- Interleukin-10 (−819 C/T) and Tumor Necrosis Factor-α (−308 G/A) Gene Variants Influence Gastritis and Lymphoid Follicle DevelopmentDigestive Diseases and Sciences, 2007
- G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancerBiochemical and Biophysical Research Communications, 2005
- HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodVaccine, 2005
- TNF‐αPromoter Polymorphisms and Susceptibility to Human Papillomavirus 16–Associated Cervical CancerThe Journal of Infectious Diseases, 2005
- Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infectionGut, 2004
- Structural characterisation of the distal 5′ flanking region of the human interleukin-10 geneGenes & Immunity, 2001
- Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervixEuropean Journal of Cancer, 1999
- Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology, 1998
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.Journal of Experimental Medicine, 1991